Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer

Photochemistry and Photobiology

Volumn 76, Issue 4, 2002, Pages 438-445

  Chen, Qun ^a   Huang, Zheng ^a   Luck, David ^a   Beckers, Jill ^a   Brun, Pierre Herve ^b   Wilson, Brian C ^c   Scherz, Avigdor ^d   Salomon, Yoram ^d   Hetzel, Fred W ^a  

^a Highlands Presbyterian St Luke's Podiatric Medicine and Surgery Residency Program   (United States)

^b Steba Biotech ^*  (France)

^c UNIVERSITY OF TORONTO   (Canada)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOSENSITIZING AGENT; TOOKAD; UNCLASSIFIED DRUG; WST 09; BACTERIOCHLOROPHYLL; PALLADIUM-BACTERIOPHEOPHORBIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CATHETER ABLATION; CONTROLLED STUDY; DOG; DOSIMETRY; HISTOPATHOLOGY; MALE; NECROSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PROSTATE CANCER; RECURRENT CANCER; URETHRA INJURY; ANIMAL; DRUG EFFECT; PHOTOCHEMOTHERAPY; PROSTATE; PROSTATE TUMOR;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; BACTERIOCHLOROPHYLLS; DOGS; MALE; MODELS, ANIMAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0036780492     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2002)076<0438:PSINCP>2.0.CO;2     Document Type: Article

References (41)

1. Boring, C. C., T. X. Squires and T. Tong (1994) Cancer statistics. Can. J. Clin. 44, 7-26.
2. Paulson, D. F. (1988) Randomized series of treatment with surgery versus radiation for prostate adenocarcinoma. In Consensus Development Conference on the Management of Clinically Localized Prostate Cancer (Edited by R. I. Wittes), pp. 121-137. Government Printing Office, Washington, DC. [NIH publication no. 88-3005. NCI Monographs 7]
3. Lepor, H. and P. C. Walsh (1988) Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the John Hopkins Hospital. In Consensus Development Conference on the Management of Clinically Localized Prostate Cancer (Edited by R. I. Wittes), pp. 117-122. Government Printing Office, Washington, DC. [NIH publication no. 88-3005. NCI Monographs 7]
4. Catalona, W. J. (1994) Management of cancer of the prostate. N. Eng. J. Med. 331, 996-1004.
5. Stamey, T. A. (1993) Irradiation as primary treatment for prostate cancer. Am. Urol. Assoc. Today 6, 14.
6. Chen, Q. and F. W. Hetzel (1998) Laser dosimetry studies in the prostate. J. Clin. Laser Med. Surg. 16, 9-12.
7. Onik, G. (2001) Image-guided prostate cryosurgery: state of the art. Cancer Control 8, 522-531.
8. Chaussy, C. and S. Thuroff (2001) Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J. Endourol. 15, 437-440.
9. Henderson, B. W. and T. J. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-157.
10. McPhee, M. S., C. W. Thorndyke, G. Thomas, J. Tulip, D. Chapman and W. H. Lakey (1984) Interstitial applications of laser irradiation in hematoporphyrin derivative-photosensitized Dunning R3327 prostate cancers. Lasers Surg. Med. 4, 93-98.
11. Moore, R. B., J. D. Chapman, J. R. Mercer, R. H. Mannan, L. I. Wiebe, A. J. McEwan and M. S. McPhee (1993) Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J. Nucl. Med. 34, 405-411.
12. Momma, T., M. R. Hamblin, H. C. Wu and T. Hasan (1998) Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res. 58, 5425-5431.
13. Colasanti, A., A. Kisslinger, R. Liuzzi, M. Quarto, P. Riccio, G. Roberti, D. Tramontano and F. Villani (2000) Hypericin photosensitization of tumor and metastatic cell lines of human prostate. J. Photochem. Photobiol. B: Biol 54, 103-107.
14. Xie, X., J. B. Hudson and E. S. Guns (2001) Tumor-specific and photodependent cytotoxicity of hypericin in the human LNCaP prostate tumor models. Photochem. Photobiol. 74, 221-225.
15. Chen, Q., B. C. Wilson, S. D. Shetty, M. S. Patterson, J. C. Cerny and F. W. Hetzel (1997) Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat. Res. 147, 86-91.
16. Lee, L. K., C. Whitehurst, M. L. Pantelides and J. V. Moore (1995) In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland. Photochem. Photobiol. 62, 882-886.
17. Lee, L. K., C. Whitehurst, M. L. Pantelides and J. V. Moore (1995) Interstitial photodynamic therapy in the canine prostate. Br. J. Urol. 80, 898-902.
18. Selman, S. H., R. W. Keck and J. A. Hampton (1996) Transperineal photodynamic ablation of the canine prostate. J. Urol. 156, 258-260.
19. Selman, S. H., D. Albrecht, R. W. Keck, P. Brennan and S. Kondo (2001) Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. J. Urol. 165, 1795-1801.
20. Chang, S., G. A. Buonaccorsi, A. J. MacRobert and S. G. Bown (1997) Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX. The Prostate 32, 89-98.
21. Chang, S., G. Buonaccorsi, A. MacRobert and S. G. Bown (1996) Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) Chlorin. Int. J. Cancer 67, 555-562.
22. Hsi, R. A., A. Kapatkin, J. Strandberg, T. Zhu, T. Vulcan, M. Solonenko, C. Rodriguez, J. Chang, M. Saunders, N. Mason and S. Hahn (2001) Photodynamic therapy in the canine prostate using motexafin lutetium. Clin. Cancer Res. 7, 651-660.
23. Scherz, A., Y. Salomon, H. Scheer and A. Brandis (1999) Palladium-substituted bacteriochlorophyll derivatives and use thereof. International PCT patent application no. PCT/IL99/00673.
24. Wagnieres, G., C. Hadjur, P. Grosjean, D. Braichotte, J. F. Savary, P. Monnier and H. van den Bergh (1998) Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem. Photobiol. 68, 382-387.
25. van Geel, I. P., H. Oppelaar, Y. G. Oussoren, M. A. van der Valk and F. A. Stewart (1995) Photosensitizing efficacy of MTHPC-PDT compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin. Int. J. Cancer 60, 388-394.
26. Chen, J. Y., N. K. Mak, J. M. Wen, W. N. Leung, S. C. Chen, M. C. Fung and N. H. Cheung (1998) A comparison of the photodynamic effects of temoporfin (mTHPC) and MC540 on leukemia cells: efficacy and apoptosis. Photochem. Photobiol. 68, 545-554.
27. Regula, J., B. Ravi, J. Bedwell, A. J. MacRobert and S. G. Bown (1994) Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br. J. Cancer 70, 248-254.
28. Bedwell, J., A. J. MacRobert, D. Phillips and S. G. Bown (1992) Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumor model. Br. J. Cancer 65, 818-824.
29. Barr, H., N. Krasner, P. B. Boulos, P. Chatlani and S. G. Bown (1990) Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br. J. Surg. 77, 93-96.
30. Sheeham, D. C. and B. B. Hrapchak (1987) Theory and Practice of Histotechnology, pp. 196-197. Battelle Press, Columbus, OH.
31. Selman, S. H. and R. W. Keck (1994) The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study. J. Urol. 152, 2129-2132.
32. Zilberstein, J., S. Schreiber, M. C. Bloemers, P. Bendel, M. Neeman, E. Schechtman, F. Kohen, A. Scherz and Y. Salomon (2001) Anti vascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy. Photochem. Photobiol. 73, 257-263.
33. Nadalini, V. F., C. Giglio, G. Bruttini, N. Positano, M. Fassone, L. Fasce, M. Medica, P. de Angelis, O. Fantacci, D. Scarpati and S. Ledda (1983) Histological follow-up after implantation of grains of I-125 for prostatic cancer. J. Urol. (Paris) 89, 187-190. [In French]
34. Sheaff, M. T. and S. I. Baithum (1997) Effects of radiation on the normal prostate gland. Histopathology 30, 341-348.
35. Chen, Q., Z. Huang, D. Luck, J. Beckers, P. Brun, B. C. Wilson, A. Scherz, Y. Salomon and F. W. Hetzel (2002) WST09 (TOOKAD) mediated photodynamic therapy as an alternative modality in treatment of prostate cancer. Prog Biomed. Opt. Imaging 3, 29-39. [see also Proc. SPIE. 4612]
36. Adili, F., R. G. Statius van Eps and G. M. LaMuraglia (1999) Significance of dosimetry in photodynamic therapy of injured arteries: classification of biological responses. Photochem. Photobiol. 70, 663-668.
37. Kurohane, K., A. Tominaga, K. Sato, J. R. North, Y. Namba and N. Oku (2001) Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett. 167, 49-56.
38. Messmer, K. J. and S. R. Abel (2001) Verteporfin for age-related macular degeneration. Ann Pharmacother. 35, 1593-1598.
39. Bowers, V. D., S. Locker, S. Ames, W. Jennings and R. J. Corry (1991) The hemodynamic effects of Cremophor-EL. Transplantation 51, 847-850.
40. Decreau, R., M. J. Richard, P. Verrando, M. Channon and M. Julliard (1990) Photodynamic activities of silicon phthalocyanines against achromic M6 melanoma cells and healthy human melanocytes and keratinocytes. J. Photochem. Photobiol. B: Biol 48, 48-56.
41. Gelderblom, H., J. Verweij, K. Nooter and A. Sparreboom (2001) Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37, 1590-1598.